A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults
Condition(s):HyperhidrosisLast Updated:June 19, 2018Completed
Hide Studies Not Open or Pending
Condition(s):HyperhidrosisLast Updated:June 19, 2018Completed
Condition(s):Atopic DermatitisLast Updated:January 10, 2022Completed
Condition(s):Infantile HemangiomasLast Updated:May 6, 2015Completed
Condition(s):Infantile HemangiomasLast Updated:January 17, 2014Withdrawn
Condition(s):Tuberous Sclerosis; Neurofibromatoses; Angiofibroma; NeurofibromaLast Updated:February 27, 2012Completed
Condition(s):Urticaria PigmentosaLast Updated:December 8, 2008Completed
Condition(s):HemangiomasLast Updated:April 19, 2018Completed
Condition(s):Enterocolitis, Necrotizing; Bacteremia; Bronchopulmonary Dysplasia; Intraventricular Hemorrhage; Periventricular Leukomalacia; Chronic Lung Disease; Ileal PerforationLast Updated:April 8, 2020Completed
Condition(s):Atopic DermatitisLast Updated:December 8, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.